Compare BKKT & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BKKT | PROF |
|---|---|---|
| Founded | 2018 | N/A |
| Country | | US |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 241.3M | 230.4M |
| IPO Year | N/A | 2017 |
| Metric | BKKT | PROF |
|---|---|---|
| Price | $10.29 | $7.00 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $13.00 | $12.00 |
| AVG Volume (30 Days) | ★ 1.2M | 164.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.14 |
| Revenue | N/A | ★ $10,680,000.00 |
| Revenue This Year | N/A | $64.23 |
| Revenue Next Year | $2.04 | $113.06 |
| P/E Ratio | ★ N/A | $6.17 |
| Revenue Growth | N/A | ★ 48.35 |
| 52 Week Low | $6.81 | $3.90 |
| 52 Week High | $49.79 | $8.95 |
| Indicator | BKKT | PROF |
|---|---|---|
| Relative Strength Index (RSI) | 39.31 | 48.14 |
| Support Level | $9.98 | $6.00 |
| Resistance Level | $11.01 | $7.11 |
| Average True Range (ATR) | 0.97 | 0.53 |
| MACD | -0.16 | 0.01 |
| Stochastic Oscillator | 11.95 | 48.28 |
Bakkt Holdings Inc operates technology that connects the digital economy by offering a platform for crypto and redeeming loyalty points. Its institutional-grade technology platform provides a custody solution that caters to more experienced market participants to store crypto and provides consumers, businesses, and institutions with the ability to buy, sell, and store crypto in a simple, intuitive digital experience accessed via application programming interfaces (APIs) or embedded web experience and Loyalty offers a full spectrum of content that clients can make available to its customers when redeeming loyalty currencies. It generates revenue in the form of Subscription and service and Transaction revenue.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.